Mireinio a lleihau canlyniadau drwy ychwanegu cysyniadau cysylltiedig
100
Liver Fluke
| Cysyniad: | Liver Fluke |
| Pwysau: | 100% |
| Parth: | Medicine and Dentistry |
59
Fluke
| Cysyniad: | Fluke |
| Pwysau: | 59% |
| Parth: | Medicine and Dentistry |
35
Vaccine
| Cysyniad: | Vaccine |
| Pwysau: | 35% |
| Parth: | Medicine and Dentistry |
35
Adult
| Cysyniad: | Adult |
| Pwysau: | 35% |
| Parth: | Medicine and Dentistry |
33
In Vitro
| Cysyniad: | In Vitro |
| Pwysau: | 33% |
| Parth: | Medicine and Dentistry |
27
Anthelmintic
| Cysyniad: | Anthelmintic |
| Pwysau: | 27% |
| Parth: | Medicine and Dentistry |
26
Fascioliasis
| Cysyniad: | Fascioliasis |
| Pwysau: | 26% |
| Parth: | Medicine and Dentistry |
23
Proteomics
| Cysyniad: | Proteomics |
| Pwysau: | 23% |
| Parth: | Medicine and Dentistry |
21
Protein Z
| Cysyniad: | Protein Z |
| Pwysau: | 21% |
| Parth: | Medicine and Dentistry |
20
Biological Marker
| Cysyniad: | Biological Marker |
| Pwysau: | 20% |
| Parth: | Medicine and Dentistry |
17
Triterpenoid
| Cysyniad: | Triterpenoid |
| Pwysau: | 17% |
| Parth: | Medicine and Dentistry |
17
Protein Superfamily
| Cysyniad: | Protein Superfamily |
| Pwysau: | 17% |
| Parth: | Medicine and Dentistry |
17
Anthelmintic Activi...
| Cysyniad: | Anthelmintic Activity |
| Pwysau: | 17% |
| Parth: | Medicine and Dentistry |
16
Parasite (Microbiol...
| Cysyniad: | Parasite (Microbiology) |
| Pwysau: | 16% |
| Parth: | Medicine and Dentistry |
16
Drug
| Cysyniad: | Drug |
| Pwysau: | 16% |
| Parth: | Medicine and Dentistry |
16
Chemotherapeutic Ag...
| Cysyniad: | Chemotherapeutic Agent |
| Pwysau: | 16% |
| Parth: | Medicine and Dentistry |
15
Pathogen
| Cysyniad: | Pathogen |
| Pwysau: | 15% |
| Parth: | Medicine and Dentistry |
15
Absence
| Cysyniad: | Absence |
| Pwysau: | 15% |
| Parth: | Medicine and Dentistry |
13
Schistosomiasis
| Cysyniad: | Schistosomiasis |
| Pwysau: | 13% |
| Parth: | Medicine and Dentistry |
13
Blood
| Cysyniad: | Blood |
| Pwysau: | 13% |
| Parth: | Medicine and Dentistry |
65
Triclabendazole
| Cysyniad: | Triclabendazole |
| Pwysau: | 65% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
33
Fasciola Hepatica
| Cysyniad: | Fasciola Hepatica |
| Pwysau: | 33% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
15
Trematode
| Cysyniad: | Trematode |
| Pwysau: | 15% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
12
Vaccine
| Cysyniad: | Vaccine |
| Pwysau: | 12% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
11
Human
| Cysyniad: | Human |
| Pwysau: | 11% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
11
Biological Marker
| Cysyniad: | Biological Marker |
| Pwysau: | 11% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
10
Host
| Cysyniad: | Host |
| Pwysau: | 10% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
10
Glutathione Transfe...
| Cysyniad: | Glutathione Transferase |
| Pwysau: | 10% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
10
Sulfoxide
| Cysyniad: | Sulfoxide |
| Pwysau: | 10% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
9
Anthelmintic Agent
| Cysyniad: | Anthelmintic Agent |
| Pwysau: | 9% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Peptide
| Cysyniad: | Peptide |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Secretory Protein
| Cysyniad: | Secretory Protein |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Drug
| Cysyniad: | Drug |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Food Poisoning
| Cysyniad: | Food Poisoning |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Parasite
| Cysyniad: | Parasite |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Absence
| Cysyniad: | Absence |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Fasciola
| Cysyniad: | Fasciola |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
5
Lead
| Cysyniad: | Lead |
| Pwysau: | 5% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
2
Chemotherapy
| Cysyniad: | Chemotherapy |
| Pwysau: | 2% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
2
Schistosomulum
| Cysyniad: | Schistosomulum |
| Pwysau: | 2% |
| Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
50
Fasciola Hepatica
| Cysyniad: | Fasciola Hepatica |
| Pwysau: | 50% |
| Parth: | Immunology and Microbiology |
36
Triclabendazole
| Cysyniad: | Triclabendazole |
| Pwysau: | 36% |
| Parth: | Immunology and Microbiology |
24
Trematoda
| Cysyniad: | Trematoda |
| Pwysau: | 24% |
| Parth: | Immunology and Microbiology |
21
Vaccine Efficacy
| Cysyniad: | Vaccine Efficacy |
| Pwysau: | 21% |
| Parth: | Immunology and Microbiology |
17
Cladistics
| Cysyniad: | Cladistics |
| Pwysau: | 17% |
| Parth: | Immunology and Microbiology |
16
Parasite
| Cysyniad: | Parasite |
| Pwysau: | 16% |
| Parth: | Immunology and Microbiology |
15
Infectious Agent
| Cysyniad: | Infectious Agent |
| Pwysau: | 15% |
| Parth: | Immunology and Microbiology |
13
Electric Potential
| Cysyniad: | Electric Potential |
| Pwysau: | 13% |
| Parth: | Immunology and Microbiology |
10
Anthelmintic Activi...
| Cysyniad: | Anthelmintic Activity |
| Pwysau: | 10% |
| Parth: | Immunology and Microbiology |
6
Fasciolosis
| Cysyniad: | Fasciolosis |
| Pwysau: | 6% |
| Parth: | Immunology and Microbiology |
5
Molecule
| Cysyniad: | Molecule |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Prevalence
| Cysyniad: | Prevalence |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Kidney Cell Line
| Cysyniad: | Kidney Cell Line |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Zoonotic
| Cysyniad: | Zoonotic |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Drug Resistance
| Cysyniad: | Drug Resistance |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
EC50
| Cysyniad: | EC50 |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
CC50
| Cysyniad: | CC50 |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Bovine
| Cysyniad: | Bovine |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Cytotoxicity
| Cysyniad: | Cytotoxicity |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
5
Secondary Metabolit...
| Cysyniad: | Secondary Metabolite |
| Pwysau: | 5% |
| Parth: | Immunology and Microbiology |
Canfuwyd 11 o arbenigwyr gydag allbwn ymchwil yn gysylltiedig i'r holl gysyniadau a ddewiswyd
Ystod Allbwn Ymchwil